Skip to main content
SpringerLink
Log in

Premature Ovarian Failure

  • Chapter
Autoimmune Diseases in Endocrinology

Part of the book series: Contemporary Endocrinology ((COE))

  • 1379 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 269.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Pettersson F, Fries H, Nillius SJ. Epidemiology of secondary amenorrhea. I. Incidence and prevalence rates. Am J Obstet Gynecol 1973; 117:80–86.

    PubMed  CAS  Google Scholar 

  2. Bachmann GA, Kemmann E. Prevalence of oligomenorrhea and amenorrhea in a college population. Am J Obstet Gynecol 1982; 144:98–102.

    PubMed  CAS  Google Scholar 

  3. Current evaluation of amenorrhea. Fertil Steril 2004; 82:266–272.

    Google Scholar 

  4. Moraes-Ruehsen M, Jones GS. Premature ovarian failure. Fertil Steril 1967; 18:440–461.

    PubMed  Google Scholar 

  5. Yen SS, Tsai CC, Vandenberg G, Rebar R. Gonadotropin dynamics in patients with gonadal dysgenesis: a model for the study of gonadotropin regulation. J Clin Endocrinol Metab 1972; 35:897–904.

    PubMed  CAS  Google Scholar 

  6. Kalantaridou SN, Davis SR, Nelson LM. Premature ovarian failure. Endocrinol Metab Clin North Am 1998; 27:989–1006.

    PubMed  CAS  Google Scholar 

  7. Rebar RW, Connolly HV. Clinical features of young women with hypergonadotropic amenorrhea. Fertil Steril 1990; 53:804–810.

    PubMed  CAS  Google Scholar 

  8. Rebar RW, Cedars MI. Hypergonadotropic forms of amenorrhea in young women. Endocrinol Metab Clin North Am 1992; 21:173–191.

    PubMed  CAS  Google Scholar 

  9. Nelson LM, Anasti JN, Kimzey LM, et al. Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab 1994; 79:1470–1475.

    PubMed  CAS  Google Scholar 

  10. Alper MM, Jolly EE, Garner PR. Pregnancies after premature ovarian failure. Obstet Gynecol 1986; 67:59S–62S.

    PubMed  CAS  Google Scholar 

  11. Kreiner D, Droesch K, Navot D, Scott R, Rosenwaks Z. Spontaneous and pharmacologically induced remissions in patients with premature ovarian failure. Obstet Gynecol 1988; 72:926–928.

    PubMed  CAS  Google Scholar 

  12. Ohsawa M, Wu MC, Masahashi T, Asai M, Narita O. Cyclic therapy resulted in pregnancy in premature ovarian failure. Obstet Gynecol 1985; 66:64S–67S.

    PubMed  CAS  Google Scholar 

  13. Kinch RA, Plunkett ER, Smout MS, Carr DH. Primary ovarian failure; a clinicopathological and cytogenetic study. Am J Obstet Gynecol 1965; 91:630–644.

    PubMed  CAS  Google Scholar 

  14. Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 1997; 18:107–134.

    PubMed  CAS  Google Scholar 

  15. Jones GS, Moraes-Ruehsen M. A new syndrome of amenorrhae in association with hypergonadotropism and apparently normal ovarian follicular apparatus. Am J Obstet Gynecol 1969; 104:597–600.

    PubMed  CAS  Google Scholar 

  16. Koninckx PR, Brosens IA. The “gonadotropin-resistant ovary” syndrome as a cause of secondary amenorrhea and infertility. Fertil Steril 1977; 28:926–931.

    PubMed  CAS  Google Scholar 

  17. Christin-Maitre S, Vasseur C, Portnoi MF, Bouchard P. Genes and premature ovarian failure. Mol Cell Endocrinol 1998; 145:75–80.

    PubMed  CAS  Google Scholar 

  18. Anasti JN. Premature ovarian failure: an update. Fertil Steril 1998; 70:1–15.

    PubMed  CAS  Google Scholar 

  19. Waggoner DD, Buist NR, Donnell GN. Long-term prognosis in galactosaemia: results of a survey of 350 cases. J Inherit Metab Dis 1990; 13:802–818.

    PubMed  CAS  Google Scholar 

  20. Coulam CB, Ryan RJ. Premature menopause. I. Etiology. Am J Obstet Gynecol 1979; 133:639–643.

    PubMed  CAS  Google Scholar 

  21. LaBarbera AR, Miller MM, Ober C, Rebar RW. Autoimmune etiology in premature ovarian failure. Am J Reprod Immunol Microbiol 1988; 16:115–122.

    PubMed  CAS  Google Scholar 

  22. Coulam CB. The prevalence of autoimmune disorders among patients with primary ovarian failure. Am J Reprod Immunol 1983; 4:63–66.

    PubMed  CAS  Google Scholar 

  23. Kamp P, Platz P, Nerup J. “Steroid-cell” antibody in endocrine diseases.Acta Endocrinol (Copenh) 1974; 76:729–740.

    CAS  Google Scholar 

  24. Board JA, Redwine FO, Moncure CW, Frable WJ, Taylor JR. Identification of differing etiologies of clinically diagnosed premature menopause. Am J Obstet Gynecol 1979; 134:936–944.

    PubMed  CAS  Google Scholar 

  25. Elder M, Maclaren N, Riley W. Gonadal autoantibodies in patients with hypogonadism and/or Addison’s disease. J Clin Endocrinol Metab 1981; 52:1137–1142.

    PubMed  CAS  Google Scholar 

  26. Coulam CB, Kempers RD, Randall RV. Premature ovarian failure: evidence for the autoimmune mechanism. Fertil Steril 1981; 36:238–240.

    PubMed  CAS  Google Scholar 

  27. Fenichel P, Sosset C, Barbarino-Monnier P et al. Prevalence, specificity and significance of ovarian antibodies during spontaneous premature ovarian failure. Hum Reprod 1997; 12:2623–2628.

    PubMed  CAS  Google Scholar 

  28. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986; 67:604–606.

    PubMed  CAS  Google Scholar 

  29. Krailo MD, Pike MC. Estimation of the distribution of age at natural menopause from prevalence data. Am J Epidemiol 1983; 117:356–361.

    PubMed  CAS  Google Scholar 

  30. Cramer DW, Xu H. Predicting age at menopause. Maturitas 1996; 23:319–326.

    PubMed  CAS  Google Scholar 

  31. Luborsky JL, Meyer P, Sowers MF, Gold EB, Santoro N. Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod 2003; 18:199–206.

    PubMed  CAS  Google Scholar 

  32. Forges T, Monnier-Barbarino P, Faure GC, Bene MC. Autoimmunity and antigenic targets in ovarian pathology. Hum Reprod Update 2004; 10:163–175.

    PubMed  CAS  Google Scholar 

  33. Wheatcroft NJ, Toogood AA, Li TC, Cooke ID, Weetman AP. Detection of antibodies to ovarian antigens in women with premature ovarian failure. Clin Exp Immunol 1994; 96:122–128.

    PubMed  CAS  Google Scholar 

  34. Luborsky J. Ovarian autoimmune disease and ovarian autoantibodies. J Womens Health Gend Based Med 2002; 11:585–599.

    PubMed  Google Scholar 

  35. Aiman J, Smentek C. Premature ovarian failure. Obstet Gynecol 1985; 66:9–14.

    PubMed  CAS  Google Scholar 

  36. Conway GS, Kaltsas G, Patel A, Davies MC, Jacobs HS. Characterization of idiopathic premature ovarian failure. Fertil Steril 1996; 65:337–341.

    PubMed  CAS  Google Scholar 

  37. Alper MM, Garner PR. Premature ovarian failure: its relationship to autoimmune disease. Obstet Gynecol 1985; 66:27–30.

    PubMed  CAS  Google Scholar 

  38. Betterle C, Rossi A, Dalla PS, et al. Premature ovarian failure: autoimmunity and natural history. Clin Endocrinol (Oxf) 1993; 39:35–43.

    CAS  Google Scholar 

  39. de Moraes RM, Blizzard RM, Garcia-Bunuel R, Jones GS. Autoimmunity and ovarian failure. Am J Obstet Gynecol 1972; 112:693–703.

    Google Scholar 

  40. Rebar RW, Erickson GF, Yen SS. Idiopathic premature ovarian failure: clinical and endocrine characteristics. Fertil Steril 1982; 37:35–41.

    PubMed  CAS  Google Scholar 

  41. Uibo R, Perheentupa J, Ovod V, Krohn KJ. Characterization of adrenal autoantigens recognized by sera from patients with autoimmune polyglandular syndrome (APS) type I. J Autoimmun 1994; 7:399–411.

    PubMed  CAS  Google Scholar 

  42. Irvine WJ, Chan MM, Scarth L, et al. Immunological aspects of premature ovarian failure associated with idiopathic Addison’s disease. Lancet 1968; 2:883–887.

    PubMed  CAS  Google Scholar 

  43. Sotsiou F, Bottazzo GF, Doniach D. Immunofluorescence studies on autoantibodies to steroid-producing cells, and to germline cells in endocrine disease and infertility. Clin Exp Immunol 1980; 39:97–111.

    PubMed  CAS  Google Scholar 

  44. Betterle C, Volpato M. Adrenal and ovarian autoimmunity. Eur J Endocrinol 1998; 138:16–25.

    PubMed  CAS  Google Scholar 

  45. Ahonen P, Miettinen A, Perheentupa J. Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure. J Clin Endocrinol Metab 1987; 64:494–500.

    PubMed  CAS  Google Scholar 

  46. Irvine WJ, Chan MM, Scarth L. The further characterization of autoantibodies reactive with extra-adrenal steroid-producing cells in patients with adrenal disorders. Clin Exp Immunol 1969; 4:489–503.

    PubMed  CAS  Google Scholar 

  47. McNatty KP, Short RV, Barnes EW, Irvine WJ. The cytotoxic effect of serum from patients with Addison’s disease and autoimmune ovarian failure on human granulosa cells in culture. Clin Exp Immunol 1975; 22:378–384.

    PubMed  CAS  Google Scholar 

  48. Krohn K, Uibo R, Aavik E, Peterson P, Savilahti K. Identification by molecular cloning of an autoantigen associated with Addison’s disease as steroid 17 alpha-hydroxylase. Lancet 1992; 339:770–773.

    PubMed  CAS  Google Scholar 

  49. Winqvist O, Gustafsson J, Rorsman F, Karlsson FA, Kampe O. Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison’s disease. J Clin Invest 1993; 92:2377–2385.

    PubMed  CAS  Google Scholar 

  50. Uibo R, Aavik E, Peterson P, et al. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison’s disease. J Clin Endocrinol Metab 1994;78:323–328.

    PubMed  CAS  Google Scholar 

  51. Arif S, Vallian S, Farzaneh F, et al. Identification of 3 beta-hydroxysteroid dehydrogenase as a novel target of steroid cell autoantibodies: association of autoantibodies with endocrine autoimmune disease. J Clin Endocrinol Metab 1996; 81:4439–4445.

    PubMed  CAS  Google Scholar 

  52. Chen S, Sawicka J, Betterle C, et al. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison’s disease, and premature ovarian failure. J Clin Endocrinol Metab 1996; 81:1871–1876.

    PubMed  CAS  Google Scholar 

  53. Peterson P, Uibo R, Peranen J, Krohn K. Immunoprecipitation of steroidogenic enzyme autoantigens with autoimmune polyglandular syndrome type I (APS I) sera; further evidence for independent humoral immunity to P450c17 and P450c21. Clin Exp Immunol 1997; 107:335–340.

    PubMed  CAS  Google Scholar 

  54. Falorni A, Laureti S, Candeloro P, et al. Steroid-cell autoantibodies are preferentially expressed in women with premature ovarian failure who have adrenal autoimmunity. Fertil Steril 2002; 78:270–279.

    PubMed  Google Scholar 

  55. Dal Pra C, Chen S, Furmaniak J, et al. Autoantibodies to steroidogenic enzymes in patients with premature ovarian failure with and without Addison’s disease. Eur J Endocrinol 2003; 148:565–570.

    PubMed  CAS  Google Scholar 

  56. Reimand K, Peterson P, Hyoty H, et al. 3beta-hydroxysteroid dehydrogenase autoantibodies are rare in premature ovarian failure. J Clin Endocrinol Metab 2000; 85:2324–2326.

    PubMed  CAS  Google Scholar 

  57. Fox H. The pathology of premature ovarian failure. J Pathol 1992; 167:357–363.

    PubMed  CAS  Google Scholar 

  58. Bakalov VK, Anasti JN, Calis KA, et al. Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46,XX spontaneous premature ovarian failure. Fertil Steril 2005; 84:958–965.

    PubMed  Google Scholar 

  59. Gloor E, Hurlimann J. Autoimmune oophoritis. Am J Clin Pathol 1984; 81:105–109.

    PubMed  CAS  Google Scholar 

  60. Bussmann L, Chiauzzi V, Cortelezzi M, Comparato M, Charreau EH. Autoinmunidad y Falla Ovàrica. Medicina (Buenos Aires) 1991; 51:471.

    Google Scholar 

  61. Bussmann L, Chiauzzi VA, Charreau EH. Anticuerpos antiovario y falla ovàrica prematura. Medicina (Buenos Aires) 1998; 58:608.

    Google Scholar 

  62. Sundblad V, Chiauzzi V, Bussmann L, Charreau E. Identificaciòn de un autoantìgeno ovàrico en pacientes con falla ovàrica prematura (POF). Medicina (Buenos Aires) 2003; 63:633.

    Google Scholar 

  63. Damewood MD, Zacur HA, Hoffman GJ, Rock JA. Circulating antiovarian antibodies in premature ovarian failure. Obstet Gynecol 1986; 68:850–854.

    PubMed  CAS  Google Scholar 

  64. Vallotton MB, Forbes AP. Antibodies to cytoplasm of ova. Lancet 1966; 2:264–265.

    PubMed  CAS  Google Scholar 

  65. Drury MI, Keelan DM, Timoney FJ, Irvine WJ. Juvenile familial endocrinopathy. Clin Exp Immunol 1970; 7:125–132.

    PubMed  CAS  Google Scholar 

  66. Williamson HO, Phansey SA, Mathur S, et al. Myasthenia gravis, premature menopause, and thyroid autoimmunity. Am J Obstet Gynecol 1980; 137:893–901.

    PubMed  CAS  Google Scholar 

  67. Kamada M, Daitoh T, Mori K, et al. Etiological implication of autoantibodies to zona pellucida in human female infertility. Am J Reprod Immunol 1992; 28:104–109.

    PubMed  CAS  Google Scholar 

  68. Gobert B, Jolivet-Reynaud C, Dalbon P, et al. An immunoreactive peptide of the FSH involved in autoimmune infertility. Biochem Biophys Res Commun 2001; 289:819–824.

    PubMed  CAS  Google Scholar 

  69. Meyer WR, Lavy G, DeCherney AH, et al. Evidence of gonadal and gonadotropin antibodies in women with a suboptimal ovarian response to exogenous gonadotropin. Obstet Gynecol 1990; 75:795–799.

    PubMed  CAS  Google Scholar 

  70. Luborsky JL, Visintin I, Boyers S, et al. Ovarian antibodies detected by immobilized antigen immunoassay in patients with premature ovarian failure. J Clin Endocrinol Metab 1990; 70:69–75.

    PubMed  CAS  Google Scholar 

  71. Van Weissenbruch MM, Hoek A, Vliet-Bleeker I, Schoemaker J, Drexhage H. Evidence for existence of immunoglobulins that block ovarian granulosa cell growth in vitro. A putative role in resistant ovary syndrome? J Clin Endocrinol Metab 1991; 73:360–367.

    PubMed  Google Scholar 

  72. Tang VW, Faiman C. Premature ovarian failure: a search for circulating factors against gonadotropin receptors. Am J Obstet Gynecol 1983; 146:816–821.

    PubMed  CAS  Google Scholar 

  73. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 46-1986. A 26-year-old woman with secondary amenorrhea. N Engl J Med 1986; 315:1336–1343.

    Google Scholar 

  74. Chiauzzi V, Cigorraga S, Escobar ME, Rivarola MA, Charreau EH. Inhibition of follicle-stimulating hormone receptor binding by circulating immunoglobulins. J Clin Endocrinol Metab 1982; 54:1221–1228.

    PubMed  CAS  Google Scholar 

  75. Chiauzzi VA, Bussmann L, Calvo JC, Sundblad V, Charreau EH. Circulating immunoglobulins that inhibit the binding of follicle-stimulating hormone to its receptor: a putative diagnostic role in resistant ovary syndrome? Clin Endocrinol (Oxf) 2004; 61:46–54.

    CAS  Google Scholar 

  76. Austin GE, Coulam CB, Ryan RJ. A search for antibodies to luteinizing hormone receptors in premature ovarian failure. Mayo Clin Proc 1979; 54:394–400.

    PubMed  CAS  Google Scholar 

  77. Escobar ME, Cigorraga SB, Chiauzzi VA, Charreau EH, Rivarola MA. Development of the gonadotrophic resistant ovary syndrome in myasthenia gravis: suggestion of similar autoimmune mechanisms. Acta Endocrinol (Copenh) 1982; 99:431–436.

    CAS  Google Scholar 

  78. Charreau EH, Cigorraga S, Chiauzzi V, Escobar ME,Rivarola MA. Receptors and antireceptors of the ovary. In: Tozzini RI, Reeves G, Pineda RL, editors. Endocrine Physiopathology of the Ovary. Elsevier/North Holland, Biomedical Press, 1980: 191–205.

    Google Scholar 

  79. Charreau EH, Chiauzzi V, Cigorraga S, Escobar ME, Rivarola M. Immunoglobulin anti FSH receptor in the resistant ovary syndrome. In: Thomas G. Muldoon, Virendra B. Mahesh and Bautista Palrez- Baltester, editors. Recent Advances in Fertility Research, Part A. Alan R. Liss, Inc. 150 Fifth Avenue,

    Google Scholar 

  80. Dias JA, Gates SA, Reichert LE Jr. Evidence for the presence of follicle-stimulating hormone receptor antibody in human serum. Fertil Steril 1982; 38:330–338.

    PubMed  CAS  Google Scholar 

  81. Bannatyne P, Russell P, Shearman RP. Autoimmune oophoritis: a clinicopathologic assessment of 12 cases. Int J Gynecol Pathol 1990; 9:191–207.

    PubMed  CAS  Google Scholar 

  82. Massin N, Gougeon A, Meduri G, et al. Significance of ovarian histology in the management of patients presenting a premature ovarian failure. Hum Reprod 2004; 19:2555–2560.

    PubMed  CAS  Google Scholar 

  83. Pache TD, Wladimiroff JW, de Jong FH, Hop WC, Fauser BC. Growth patterns of nondominant ovarian follicles during the normal menstrual cycle. Fertil Steril 1990; 54:638–642.

    PubMed  CAS  Google Scholar 

  84. Mehta AE, Matwijiw I, Lyons EA, Faiman C. Noninvasive diagnosis of resistant ovary syndrome by ultrasonography. Fertil Steril 1992; 57:56–61.

    PubMed  CAS  Google Scholar 

  85. Winqvist O, Gebre-Medhin G, Gustafsson J, et al. Identification of the main gonadal autoantigens in patients with adrenal insufficiency and associated ovarian failure. J Clin Endocrinol Metab 1995; 80:1717–1723.

    PubMed  CAS  Google Scholar 

  86. Betterle C, Volpato M, Pedini B, et al. Adrenal-cortex autoantibodies and steroid-producing cells autoantibodies in patients with Addison’s disease: comparison of immunofluorescence and immunoprecipitation assays. J Clin Endocrinol Metab 1999; 84:618–622.

    PubMed  CAS  Google Scholar 

  87. Coulam CB, Ryan RJ. Prevalence of circulating antibodies directed toward ovaries among women with premature ovarian failure. Am J Reprod Immunol Microbiol 1985; 9:23–24.

    PubMed  CAS  Google Scholar 

  88. Ho PC, Tang GW, Fu KH, Fan MC, Lawton JW. Immunologic studies in patients with premature ovarian failure. Obstet Gynecol 1988; 71:622–626.

    PubMed  CAS  Google Scholar 

  89. Kirsop R, Brock CR, Robinson BG, et al. Detection of anti-ovarian antibodies by indirect immunofluorescence in patients with premature ovarian failure. Reprod Fertil Dev 1991; 3:537–541.

    PubMed  CAS  Google Scholar 

  90. Wheatcroft NJ, Salt C, Milford-Ward A, Cooke ID, Weetman AP. Identification of ovarian antibodies by immunofluorescence, enzyme-linked immunosorbent assay or immunoblotting in premature ovarian failure. Hum Reprod 1997; 12:2617–2622.

    PubMed  CAS  Google Scholar 

  91. Luborsky J, Llanes B, Davies S, et al. Ovarian autoimmunity: greater frequency of autoantibodies in premature menopause and unexplained infertility than in the general population. Clin Immunol 1999; 90:368–374.

    PubMed  CAS  Google Scholar 

  92. Gobert B, Barabarino-Monnier P, Guillet-Rosso F, Bene MC, Faure GC. Ovary antibodies after IVF. Lancet 1990; 335:723.

    Google Scholar 

  93. Dewhurst CJ, de Koos EB, Ferreira HP. The resistant ovary syndrome. Br J Obstet Gynaecol 1975; 82:341–345.

    PubMed  CAS  Google Scholar 

  94. Starup J, Sele V, Henriksen B. Amenorrhoea associated with increased production of gonadotrophins and a morphologically normal ovarian follicular apparatus. Acta Endocrinol (Copenh) 1971; 66:248–256.

    CAS  Google Scholar 

  95. Van Campenhout J, Vauclair R, Maraghi K. Gonadotropin–resistant ovaries in primary amenorrhea. Obstet Gynecol 1972; 40:6–12.

    PubMed  Google Scholar 

  96. Anasti JN, Kalantaridou SN, Kimzey LM, Defensor RA, Nelson LM. Bone loss in young women with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol 1998; 91:12–15.

    PubMed  CAS  Google Scholar 

  97. Davis SR, Burger HG. The rationale for physiological testosterone replacement in women. Baillieres Clin Endocrinol Metab 1998; 12:391–405.

    PubMed  CAS  Google Scholar 

  98. Davis SR, McCloud P, Strauss BJ, Burger H. Testosterone enhances estradiol’s effects on postmenopausal bone density and sexuality. Maturitas 1995; 21:227–236.

    PubMed  CAS  Google Scholar 

  99. Wright CS, Jacobs HS. Spontaneous pregnancy in a patient with hypergonadotrophic ovarian failure. Br J Obstet Gynaecol 1979; 86:389–392.

    PubMed  CAS  Google Scholar 

  100. Rabinowe SL, Berger MJ, Welch WR, Dluhy RG. Lymphocyte dysfunction in autoimmune oophoritis. Resumption of menses with corticosteroids. Am J Med 1986; 81:347–350.

    PubMed  CAS  Google Scholar 

  101. Cowchock FS, McCabe JL, Montgomery BB. Pregnancy after corticosteroid administration in premature ovarian failure (polyglandular endocrinopathy syndrome). Am J Obstet Gynecol 1988; 158:118–119.

    PubMed  CAS  Google Scholar 

  102. Kalantaridou SN, Braddock DT, Patronas NJ, Nelson LM. Treatment of autoimmune premature ovarian failure. Hum Reprod 1999; 14:1777–1782.

    PubMed  CAS  Google Scholar 

  103. Barbarino-Monnier P, Gobert B, Guillet-May F, et al. Ovarian autoimmunity and corticotherapy in an in-vitro fertilization attempt. Hum Reprod 1995; 10:2006–2007.

    PubMed  CAS  Google Scholar 

  104. van Kasteren YM, Braat DD, Hemrika DJ, et al. Corticosteroids do not influence ovarian responsiveness to gonadotropins in patients with premature ovarian failure: a randomized, placebo-controlled trial. Fertil Steril 1999; 71:90–95.

    PubMed  Google Scholar 

  105. Corenblum B, Rowe T, Taylor PJ. High-dose,short-term glucocorticoids for the treatment of infertility resulting from premature ovarian failure. Fertil Steril 1993; 59:988–991.

    PubMed  CAS  Google Scholar 

  106. Blumenfeld Z, Halachmi S, Peretz BA, et al. Premature ovarian failure–the prognostic application of autoimmunity on conception after ovulation induction. Fertil Steril 1993; 59:750–755.

    PubMed  CAS  Google Scholar 

  107. Bateman BG, Nunley WC Jr, Kitchin JD III. Reversal of apparent premature ovarian failure in a patient with myasthenia gravis. Fertil Steril 1983; 39:108–110.

    PubMed  CAS  Google Scholar 

  108. Lundberg PO, Persson BH. Disappearance of amenorrhea after thymectomy. A case report. Acta Soc Med Ups 1969; 74:206–208.

    PubMed  CAS  Google Scholar 

  109. Sauer MV, Paulson RJ, Ary BA, Lobo RA. Three hundred cycles of oocyte donation at the University of Southern California: assessing the effect of age and infertility diagnosis on pregnancy and implantation rates. J Assist Reprod Genet 1994; 11:92–96.

    PubMed  CAS  Google Scholar 

  110. Sung L, Bustillo M, Mukherjee T, et al. Sisters of women with premature ovarian failure may not be ideal ovum donors. Fertil Steril 1997; 67:912–916.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Victoria Sundblad Phd
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Violeta A.Chiauzzi PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eduardo H. Charreau Phd
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Anthony P. Weetman MD,DSc

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Humana Press Inc.

About this chapter

Cite this chapter

Sundblad, V., A.Chiauzzi, V., Charreau, E.H. (2007). Premature Ovarian Failure. In: Weetman, A.P. (eds) Autoimmune Diseases in Endocrinology. Contemporary Endocrinology. Humana Press. https://doi.org/10.1007/978-1-59745-517-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-517-6_14

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-733-4

  • Online ISBN: 978-1-59745-517-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation